Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immuno BCG Pasteur F vaccine.

M Gheorghiu, L Chambon, C Serié

    Developments in Biological Standardization
    |April 13, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Production of radioactive traceable reference materials for measuring radioactive pollutants in the environment.

    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2025
    Same author

    Activity standardization and determination of nuclear decay data of <sup>212</sup>Pb at LNE-LNHB and first measurements in the SIR at BIPM.

    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2025
    Same author

    Novel production method for traceable surface sources by aluminium functionalisation.

    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2023
    Same author

    MALIGNANT PARAGANGLIOMA NON-RESPONSIVE TO MIBG IN MEN2A SYNDROME.

    Acta endocrinologica (Bucharest, Romania : 2005)·2023
    Same author

    PHEOCHROMOCYTOMA-PARAGANGLIOMA: TRANSLATIONAL APPROACH FROM GENETICS TO CLINICAL NEUROENDOCRINOLOGY.

    Acta endocrinologica (Bucharest, Romania : 2005)·2019
    Same author

    [Not Available].

    Bulletin of the World Health Organization·2010

    The Immuno BCG Pasteur-F vaccine, prepared from young cultures, shows good stability for storage. This BCG vaccine remains stable for months at 4°C and years at -70°C, confirmed by multiple tests.

    Area of Science:

    • Microbiology
    • Immunology
    • Vaccine Development

    Background:

    • Bacillus Calmette-Guérin (BCG) vaccines are crucial for tuberculosis prevention.
    • Maintaining BCG vaccine stability is essential for its efficacy and safe administration.
    • The Immuno BCG Pasteur-F is a specific formulation requiring stability assessment.

    Purpose of the Study:

    • To evaluate the stability of the Immuno BCG Pasteur-F vaccine under different storage conditions.
    • To determine the optimal preservation methods for maintaining vaccine viability.

    Main Methods:

    • Preparation of Immuno BCG Pasteur-F from 7-8 day old cultures.
    • Suspension of the vaccine in Dubos' modified medium.
    • Storage of the vaccine at 4°C for up to 3 months and at -70°C for extended periods.

    Related Experiment Videos

  • Assessment of vaccine stability through colony-forming unit counts, animal biological controls, and allergy tests in children.
  • Main Results:

    • The Immuno BCG Pasteur-F vaccine demonstrated good stability when stored at 4°C for 3 months.
    • Long-term stability was observed for many years when the vaccine was preserved at -70°C.
    • Biological controls in animals and allergy tests in children corroborated the vaccine's stability.

    Conclusions:

    • Immuno BCG Pasteur-F vaccine exhibits favorable stability characteristics under recommended storage conditions.
    • The vaccine can be reliably stored for extended periods, ensuring its availability and potency.
    • These findings support the use of Immuno BCG Pasteur-F in vaccination programs.